Enovis (ENOV) Net Cash Flow Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Enovis | 1.25 Bn | 1.22 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -14.92% |
| Dec 31, 2025 | -39.21% |
| Oct 3, 2025 | -80.74% |
| Jul 4, 2025 | 15.03% |
| Apr 4, 2025 | -15.34% |
| Dec 31, 2024 | 16.81% |
| Sep 27, 2024 | 37.83% |
| Jun 28, 2024 | -15.80% |
| Mar 29, 2024 | 56.29% |
| Dec 31, 2023 | 18.06% |
| Sep 29, 2023 | -64.64% |
| Jun 30, 2023 | -5.53% |
| Mar 31, 2023 | -41.03% |
| Dec 31, 2022 | -15.79% |
| Sep 30, 2022 | -145.39% |
| Jul 1, 2022 | -62.14% |
| Apr 1, 2022 | -26.58% |
| Dec 31, 2021 | 75.35% |
| Oct 1, 2021 | 103.92% |
| Jul 2, 2021 | -129.25% |
| Apr 2, 2021 | 165.00% |
| Dec 31, 2020 | 27.95% |
| Oct 2, 2020 | -55.59% |
| Jul 3, 2020 | -159.53% |
| Apr 3, 2020 | 38.68% |
| Dec 31, 2019 | -34.26% |
| Sep 27, 2019 | -11.05% |
| Jun 28, 2019 | 37.39% |
| Mar 29, 2019 | -15.15% |
| Dec 31, 2018 | 34.12% |
| Sep 28, 2018 | -4.61% |
| Jun 29, 2018 | -47.65% |
| Mar 30, 2018 | 14.90% |
| Dec 31, 2017 | 18.43% |
| Sep 29, 2017 | 15.09% |
| Jun 30, 2017 | 39.92% |
| Mar 31, 2017 | -15.29% |
| Dec 31, 2016 | 14.58% |
| Sep 30, 2016 | -3.10% |
| Jul 1, 2016 | -21.30% |
| Apr 1, 2016 | 22.28% |
| Dec 31, 2015 | -25.42% |
| Sep 25, 2015 | 27.48% |